Big Pharmacy Inc. acquired Small Pharmacy Inc. for $15 billion cash on January 1st, 2025. The assets
Question:
Big Pharmacy Inc. acquired Small Pharmacy Inc. for $15 billion cash on January 1st, 2025. The assets purchased include finite-life intangible assets with a fair value of $9 billion, in process R&D with a fair value of $4 billion, and property with a book value (after accounting for accumulated depreciation) of $2.5 billion. Big Pharmacy also took over a $6.5 billion liability of Small Pharmacy Inc. Record the journal entry for this acquisition.
Big Pharmacy’s scientists took over a project started by Small Pharmacy scientists and used the documented work of Small Pharmacy scientists (i.e., the in-process R&D) to successfully develop a new vaccine. Big Pharmacy’s scientists spent a total of $750 million in cash to conduct this work in 2026. Record the journal entry for this $750 million spending (assume for tractability that all cash was spent on Dec 31st, 2026, for simplicity and all research activity was conducted on the same day itself).
Financial Reporting Financial Statement Analysis and Valuation a strategic perspective
ISBN: 978-1337614689
9th edition
Authors: James M. Wahlen, Stephen P. Baginski, Mark Bradshaw